Skin Investigation and Technology Hamburg GmbH Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2017
NCT03252730
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Skin Investigation and Technology Hamburg GmbH

Active Ingredients

Drugs in Other Trials (1)

wo 4260 (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1